Lepra recurrent developed after termination of antileprotic therapy
Lepra is an infectious disease, granulomatosis caused by Mycobacterium leprae. It is characterized with prolonged latent period (from 3-5 years to several decades), low transmission, generally lesions of skin and peripheral nervous system. The recurrent of disease is possible after the termination o...
Saved in:
Main Authors: | A. A. Kubanov (Author), A. E. Karamova (Author), V. G. Semenova (Author), V. A. Smoliannikova (Author), M. A. Nefedova (Author) |
---|---|
Format: | Book |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coamplification of Mycobacterium leprae genome sections by real-time PCR: Detection of the pathogen and the possibility of a semi-quantitative assessment of the bacterial load
by: D. A. Verbenko, et al.
Published: (2020) -
Antileprotic medication induced psychosis in a patient of tuberous sclerosis: A case report
by: Udit Kumar Panda, et al.
Published: (2017) -
The genetic determinants of <i>Mycobacterium leprae</i> resistance to antimicrobial drugs
by: Dmitry A. Verbenko, et al.
Published: (2021) -
Therapy of patients with congenital epidermolysis bullosa using modern non-adherent wound dressings
by: A. A. Kubanov, et al.
Published: (2019) -
Directions for the development of Vestnik Dermatologii i Venerologii
by: A. A. Kubanova, et al.
Published: (2017)